Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

3.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.6K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Direct Motor Pathways01:11

Direct Motor Pathways

4.7K
The direct motor pathways, also known as the pyramidal tracts, are a group of neural pathways that originate in the brain and descend through the spinal cord. They control the voluntary movement of the body. There are two major direct motor pathways: the corticospinal and the corticobulbar tracts.
The corticospinal tract is responsible for the voluntary movement of the limbs and trunk. It originates in the cerebral cortex of the brain and descends through the cerebrum's internal capsule and...
4.7K
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

17
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
17
Motor Units01:13

Motor Units

14.2K
The motor unit is a fundamental component of the neuromuscular system and plays a crucial role in coordinating muscle contractions. It consists of a somatic motor neuron, which connects and controls multiple skeletal muscle fibers, forming a single functional segment. The axon of the motor neuron branches out and establishes synaptic connections known as neuromuscular junctions with individual muscle fibers within the motor unit.
Motor units come in different sizes, with smaller units...
14.2K
Motor Units00:46

Motor Units

53.8K
A motor unit consists of two main components: a single efferent motor neuron (i.e., a neuron that carries impulses away from the central nervous system) and all of the muscle fibers it innervates. The motor neuron may innervate multiple muscle fibers, which are single cells, but only one motor neuron innervates a single muscle fiber.
53.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impaired kinesthesia and cerebral integration during tendon vibration in amyotrophic lateral sclerosis.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2026
Same author

Muscle MRI and Muscle Ultrasound Applications in MND/ALS: Academic Insights and Clinical Opportunities.

European journal of neurology·2026
Same author

Putative mitochondrial components of frontotemporal lobar degeneration: topological correlations between mitochondrial density and atrophy in FTLD/FTD phenotypes.

Journal of neurology·2025
Same author

Anatomical Associations Between Focal Mitochondrial Metabolism and Patterns of Neurodegeneration in Amyotrophic Lateral Sclerosis.

Annals of neurology·2025
Same author

Machine-Learning Applications in Frontotemporal Dementia: Challenges, Prospects and Viable Clinical Applications.

European journal of neurology·2025
Same author

Toward therapeutic trials in primary lateral sclerosis.

Amyotrophic lateral sclerosis & frontotemporal degeneration·2025

Related Experiment Video

Updated: Apr 28, 2026

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
06:35

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration

Published on: June 15, 2018

22.7K

Driving with Motor Neuron Disease: Disease-Specific Considerations, Multi-Domain Assessments and Support Strategies.

Jana Kleinerova1, Jane Tully2, Jasmin Lope1

  • 1Computational Neuroimaging Group (CNG), School of Medicine, Trinity College Dublin, D02 PN40 Dublin, Ireland.

Brain Sciences
|April 27, 2026
PubMed
Summary

Driving safety in motor neuron diseases (MNDs) requires comprehensive assessment beyond motor skills. This review highlights the need to address non-motor symptoms and individualize strategies to maintain patient independence and quality of life.

Keywords:
Amyotrophic Lateral SclerosisKennedy’s diseaseSpinal Muscular Atrophydrivingmotor neuron diseasepoliomyelitisprimary lateral sclerosis

More Related Videos

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

9.0K
Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
06:51

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Published on: August 10, 2018

9.3K

Related Experiment Videos

Last Updated: Apr 28, 2026

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
06:35

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration

Published on: June 15, 2018

22.7K
ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

9.0K
Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
06:51

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Published on: August 10, 2018

9.3K

Area of Science:

  • Neurology
  • Neurodegenerative Diseases
  • Rehabilitation Medicine

Background:

  • Motor neuron diseases (MNDs) are a diverse group of neurodegenerative conditions impacting motor, cognitive, and respiratory functions.
  • Existing guidelines address general MND management but lack comprehensive reviews on driving safety specific to MND phenotypes.
  • Driving safety evaluations for MND patients often overlook crucial non-motor symptoms and understudied, slower-progressing MND types.

Purpose of the Study:

  • To comprehensively review driving safety aspects in MNDs, including understudied phenotypes.
  • To raise awareness of non-motor symptoms affecting driving safety in MND.
  • To explore strategies supporting safe driving and patient independence.

Main Methods:

  • Systematic literature review focusing on driving safety in various MND phenotypes.
  • Analysis of clinical features, assessment approaches, and intervention strategies for MND patients.
  • Examination of disease-specific and universal factors influencing driving safety.

Main Results:

  • MNDs present unique challenges to driving safety due to motor, cognitive, behavioral, and respiratory impairments.
  • Current literature predominantly focuses on amyotrophic lateral sclerosis, neglecting rarer MND forms.
  • Non-motor symptoms significantly impact driving ability and necessitate tailored assessments.

Conclusions:

  • A systematic, domain-by-domain assessment is crucial for evaluating driving safety in MND.
  • Individualized strategies and adaptations can enable safe driving, preserving patient independence and quality of life.
  • Increased awareness of non-motor aspects is vital for comprehensive MND driving safety management.